 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/13/2025 |
$0.20 |
$0.20 |
$0.18 |
$0.18 |
1.96M | | 01/14/2025 |
$0.17 |
$0.18 |
$0.17 |
$0.17 |
1.96M | | 01/15/2025 |
$0.16 |
$0.17 |
$0.14 |
$0.15 |
3.57M | | 01/16/2025 |
$0.14 |
$0.15 |
$0.14 |
$0.14 |
4.38M | | 01/17/2025 |
$0.15 |
$0.16 |
$0.14 |
$0.15 |
2.70M |
|
|
| Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. It has a next generation bioconjugation platform, called VersAptx. The VersAptx platform is a versatile and adaptable, next generation bioconjugation platform. Its product candidates include VIP943 (CD123-KSPi), VIP924 (CXCR5-KSPi), VIP236, and Enitociclib (P-TEFb/CDK9 inhibitor). VIP943 is a potential anti-CD123 ADC created with its VersAptx Platform. It consists of an anti-CD123 antibody, a novel legumain-cleavable linker, and a KSPi payload enhanced with its CellTrapper technology. | |
|
Vincerx Pharma (VINC) has the following price history information. Looking back at VINC historical stock prices for the last five trading days, on January 13, 2025, VINC opened at $0.20, traded as high as $0.20 and as low as $0.18, and closed at $0.18. Trading volume was a total of 1.96M shares. On January 14, 2025, VINC opened at $0.17, traded as high as $0.18 and as low as $0.17, and closed at $0.17. Trading volume was a total of 1.96M shares. On January 15, 2025, VINC opened at $0.16, traded as high as $0.17 and as low as $0.14, and closed at $0.15. Trading volume was a total of 3.57M shares. On January 16, 2025, VINC opened at $0.14, traded as high as $0.15 and as low as $0.14, and closed at $0.14. Trading volume was a total of 4.38M shares. On January 17, 2025, VINC opened at $0.15, traded as high as $0.16 and as low as $0.14, and closed at $0.15. Trading volume was a total of 2.70M shares.
VINC Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Vincerx Pharma shares, starting with a $10,000 purchase of VINC, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/28/2020 |
|
| End date: |
01/17/2025 |
|
| Start price/share: |
$9.35 |
|
| End price/share: |
$0.15 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.37% |
|
| Average Annual Total Return: |
-58.81% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$162.61 |
|
| Years: |
4.64 |
|
|
|
| Date |
Close |
| 01/13/2025 | $0.18 | | 01/14/2025 | $0.17 | | 01/15/2025 | $0.15 | | 01/16/2025 | $0.14 | | 01/17/2025 | $0.15 |
|
|
Free VINC Email Alerts:
